Zevra Therapeutics, Inc.
ZVRA
Cena:
Valuace
70
Růst
63
Zdraví
50
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 4.1 mil | 8.53% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK, INC. | 4.5 mil | 8.06% | 0.00% | 0.00% | 2024-09-30 |
| WOODLINE PARTNERS LP | 3.5 mil | 6.24% | 0.00% | 0.12% | 2024-03-31 |
| VANGUARD GROUP INC | 3.3 mil | 5.91% | 0.00% | 0.00% | 2021-03-31 |
| FMR LLC | 3.2 mil | 5.81% | 0.00% | 0.00% | 2022-03-31 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 2.5 mil | 4.56% | 0.34% | 0.87% | 2023-09-30 |
| RUBRIC CAPITAL MANAGEMENT LP | 2.0 mil | 3.57% | 0.10% | 0.26% | 2024-09-30 |
| STATE STREET CORP | 1.6 mil | 2.82% | 0.00% | 0.00% | 2021-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4 mil | 2.48% | 0.00% | 0.00% | 2021-03-31 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.3 mil | 2.38% | 18.86% | 23.23% | 2024-03-31 |
| AIGH CAPITAL MANAGEMENT LLC | 1.2 mil | 2.17% | 1.53% | 1.53% | 2024-06-30 |
| MORGAN STANLEY | 1.2 mil | 2.16% | 0.00% | 0.00% | 2021-03-31 |
| LEGAL & GENERAL GROUP PLC | 1.2 mil | 2.10% | 0.00% | 0.00% | 2023-06-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.2 mil | 2.09% | 0.01% | 0.01% | 2026-03-31 |
| ROYCE & ASSOCIATES LP | 988.67 tis | 1.79% | 0.01% | 0.09% | 2025-09-30 |
| 683 CAPITAL MANAGEMENT, LLC | 975.00 tis | 1.76% | 0.12% | 0.47% | 2023-12-31 |
| D. E. SHAW & CO., INC. | 846.46 tis | 1.53% | 0.00% | 0.00% | 2024-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 842.32 tis | 1.52% | 0.01% | 0.01% | 2025-06-30 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 775.00 tis | 1.40% | 0.17% | 0.79% | 2025-06-30 |
| GOLDMAN SACHS GROUP INC | 743.12 tis | 1.34% | 0.00% | 0.00% | 2021-03-31 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 715.00 tis | 1.31% | 1.10% | 6.22% | 2024-09-30 |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 651.15 tis | 1.18% | 0.09% | 2.47% | 2021-12-31 |
| VESTAL POINT CAPITAL, LP | 525.00 tis | 1.10% | 0.28% | 0.28% | 2024-09-30 |
| MILLENNIUM MANAGEMENT LLC | 590.27 tis | 1.07% | 0.00% | 0.00% | 2024-09-30 |
| DIMENSIONAL FUND ADVISORS LP | 554.80 tis | 1.00% | 0.00% | 0.00% | 2025-12-31 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 506.03 tis | 0.91% | 0.00% | 0.00% | 2025-06-30 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 480.00 tis | 0.87% | -1.93% | 1.79% | 2024-09-30 |
| 466.30 tis | 0.84% | 0.00% | 0.00% | 2026-03-31 | |
| TUDOR INVESTMENT CORP ET AL | 443.11 tis | 0.80% | 0.00% | 0.01% | 2025-09-30 |
| MARSHALL WACE, LLP | 439.95 tis | 0.80% | 0.00% | 0.00% | 2025-09-30 |
| NORTHERN TRUST CORP | 436.95 tis | 0.79% | 0.00% | 0.00% | 2021-03-31 |
| ALGERT GLOBAL LLC | 418.55 tis | 0.76% | 0.07% | 0.07% | 2025-09-30 |
| UBS GROUP AG | 422.05 tis | 0.76% | 0.00% | 0.00% | 2021-12-31 |
| STRATOS WEALTH PARTNERS, LTD. | 408.00 tis | 0.74% | 0.00% | 0.04% | 2021-09-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 350.00 tis | 0.73% | 0.55% | 0.55% | 2024-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 395.88 tis | 0.72% | 0.00% | 0.00% | 2026-03-31 |
| JPMORGAN CHASE & CO | 378.93 tis | 0.69% | 0.00% | 0.00% | 2021-06-30 |
| MYSTIC ASSET MANAGEMENT, INC. | 361.28 tis | 0.65% | 0.08% | 0.78% | 2021-12-31 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 350.50 tis | 0.63% | 0.05% | 0.05% | 2026-03-31 |
| IKARIAN CAPITAL, LLC | 292.77 tis | 0.61% | 0.33% | 0.33% | 2024-12-31 |
| BARCLAYS PLC | 332.44 tis | 0.61% | 0.00% | 0.00% | 2022-09-30 |
| PROPEL BIO MANAGEMENT, LLC | 282.42 tis | 0.51% | 1.18% | 1.66% | 2024-09-30 |
| CAPTION MANAGEMENT, LLC | 255.24 tis | 0.46% | -0.02% | 0.01% | 2024-09-30 |
| CITADEL ADVISORS LLC | 243.40 tis | 0.44% | 0.00% | 0.00% | 2021-03-31 |
| JANNEY MONTGOMERY SCOTT LLC | 236.83 tis | 0.43% | 0.00% | 0.01% | 2021-03-31 |
| TREXQUANT INVESTMENT LP | 209.70 tis | 0.37% | -0.01% | 0.02% | 2025-09-30 |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 177.90 tis | 0.37% | 0.00% | 0.01% | 2024-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200.00 tis | 0.36% | 0.00% | 0.00% | 2024-09-30 |
| VERITION FUND MANAGEMENT LLC | 193.51 tis | 0.35% | 0.01% | 0.01% | 2025-03-31 |
| NUVEEN, LLC | 192.59 tis | 0.35% | 0.00% | 0.00% | 2025-03-31 |
| TFG ASSET MANAGEMENT GP LTD | 192.52 tis | 0.34% | 0.36% | 0.36% | 2025-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 186.58 tis | 0.34% | 0.00% | 0.00% | 2021-03-31 |
| SQUAREPOINT OPS LLC | 182.86 tis | 0.33% | 0.00% | 0.00% | 2023-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 181.13 tis | 0.32% | 0.00% | 0.00% | 2025-09-30 |
| JANE STREET GROUP, LLC | 178.70 tis | 0.32% | 0.00% | 0.00% | 2024-09-30 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 177.16 tis | 0.32% | 0.01% | 0.06% | 2025-12-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 153.08 tis | 0.32% | 0.00% | 0.00% | 2023-06-30 |
| KOVACK ADVISORS, INC. | 175.23 tis | 0.32% | 0.02% | 0.09% | 2021-06-30 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 150.00 tis | 0.31% | 0.11% | 0.11% | 2024-09-30 |
| BANK OF NEW YORK MELLON CORP | 172.43 tis | 0.31% | 0.00% | 0.00% | 2021-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 170.31 tis | 0.30% | 0.00% | 0.00% | 2025-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 161.98 tis | 0.29% | 0.00% | 0.00% | 2021-06-30 |
| PHOCAS FINANCIAL CORP. | 159.42 tis | 0.29% | 0.23% | 0.23% | 2026-03-31 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 151.42 tis | 0.27% | 0.00% | 0.00% | 2025-09-30 |
| SIMPLIFY ASSET MANAGEMENT INC. | 147.00 tis | 0.27% | -0.04% | 0.03% | 2024-09-30 |
| ACADIAN ASSET MANAGEMENT LLC | 149.64 tis | 0.27% | 0.00% | 0.00% | 2025-09-30 |
| BANK OF AMERICA CORP /DE/ | 146.36 tis | 0.26% | 0.00% | 0.00% | 2021-06-30 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 121.23 tis | 0.22% | 0.00% | 0.00% | 2025-06-30 |
| ROYAL BANK OF CANADA | 118.24 tis | 0.22% | 0.00% | 0.00% | 2021-03-31 |
| LMR PARTNERS LLP | 100.00 tis | 0.21% | 0.00% | 0.01% | 2024-09-30 |
| READYSTATE ASSET MANAGEMENT LP | 111.52 tis | 0.20% | -0.14% | 0.03% | 2024-12-31 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 95.14 tis | 0.20% | 0.00% | 0.01% | 2022-06-30 |
| J. GOLDMAN & CO LP | 108.00 tis | 0.20% | -0.07% | 0.02% | 2024-09-30 |
| CREDIT AGRICOLE S A | 106.00 tis | 0.20% | 0.00% | 0.00% | 2024-06-30 |
| BOOTHBAY FUND MANAGEMENT, LLC | 85.82 tis | 0.18% | 0.02% | 0.02% | 2024-12-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 88.41 tis | 0.16% | 0.00% | 0.00% | 2025-06-30 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 83.25 tis | 0.15% | 0.05% | 0.05% | 2025-06-30 |
| RHUMBLINE ADVISERS | 83.22 tis | 0.15% | 0.00% | 0.00% | 2023-06-30 |
| ARETE WEALTH ADVISORS, LLC | 74.79 tis | 0.14% | 0.00% | 0.05% | 2021-03-31 |
| GTS SECURITIES LLC | 61.60 tis | 0.13% | 0.00% | 0.00% | 2024-09-30 |
| CITIGROUP INC | 60.13 tis | 0.11% | 0.00% | 0.00% | 2021-06-30 |
| DEUTSCHE BANK AG\ | 45.68 tis | 0.08% | 0.00% | 0.00% | 2023-09-30 |
| BNP PARIBAS ARBITRAGE, SNC | 42.95 tis | 0.08% | 0.00% | 0.00% | 2024-12-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 41.93 tis | 0.08% | 0.00% | 0.00% | 2024-09-30 |
| ENTRYPOINT CAPITAL, LLC | 40.68 tis | 0.08% | 0.05% | 0.14% | 2024-12-31 |
| CARRET ASSET MANAGEMENT, LLC | 39.64 tis | 0.07% | 0.01% | 0.04% | 2025-03-31 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 32.80 tis | 0.07% | 0.00% | 0.00% | 2023-06-30 |
| COMMONWEALTH EQUITY SERVICES, LLC | 30.43 tis | 0.06% | 0.00% | 0.00% | 2024-06-30 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 29.95 tis | 0.06% | 0.00% | 0.00% | 2024-06-30 |
| WELLS FARGO & COMPANY/MN | 29.70 tis | 0.06% | 0.00% | 0.00% | 2021-03-31 |
| IFG ADVISORS, LLC | 29.05 tis | 0.06% | 0.01% | 0.05% | 2023-06-30 |
| RAYMOND JAMES FINANCIAL INC | 26.92 tis | 0.06% | 0.00% | 0.00% | 2024-12-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | A-Award | 20000 | 0.00 | 29.5 2026 | 20000 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | A-Award | 40000 | 11.40 | 29.5 2026 | 40000 |
| Thompson Rahsaan | officer: Chief Legal & Compliance | S-Sale | 1794 | 11.30 | 13.5 2026 | 48125 |
| Bode John B | director | M-Exempt | 39200 | 4.89 | 26.3 2026 | 0 |
| Bode John B | director | M-Exempt | 39200 | 4.97 | 26.3 2026 | 19600 |
| Bode John B | director | M-Exempt | 39200 | 4.97 | 26.3 2026 | 84200 |
| Bode John B | director | M-Exempt | 39200 | 4.89 | 26.3 2026 | 123400 |
| Renz Justin A | officer | 0 | 0.00 | 19.3 2026 | 0 | |
| Renz Justin A | officer: CFO | A-Award | 300000 | 9.55 | 19.3 2026 | 300000 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 37500 | 0.00 | 10.2 2026 | 75000 |
| McFarlane Neil F. | director, officer: President and CEO | S-Sale | 14625 | 8.56 | 10.2 2026 | 387225 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 37500 | 0.00 | 10.2 2026 | 401850 |
| Schafer Joshua | officer: CCO | S-Sale | 10500 | 9.19 | 4.2 2026 | 62278 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | S-Sale | 3000 | 9.18 | 4.2 2026 | 29590 |
| McFarlane Neil F. | director, officer: President and CEO | A-Award | 125000 | 0.00 | 2.2 2026 | 125000 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 233334 | 0.00 | 2.2 2026 | 233333 |
| McFarlane Neil F. | director, officer: President and CEO | A-Award | 250000 | 8.86 | 2.2 2026 | 250000 |
| McFarlane Neil F. | director, officer: President and CEO | S-Sale | 91000 | 9.38 | 2.2 2026 | 364350 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 233334 | 0.00 | 2.2 2026 | 455350 |
| Schafer Joshua | officer: CCO | M-Exempt | 11333 | 0.00 | 2.2 2026 | 22667 |
| Schafer Joshua | officer: CCO | M-Exempt | 35334 | 0.00 | 2.2 2026 | 35333 |
| Schafer Joshua | officer: CCO | S-Sale | 3375 | 8.83 | 2.2 2026 | 37444 |
| Schafer Joshua | officer: CCO | A-Award | 37500 | 0.00 | 2.2 2026 | 37500 |
| Schafer Joshua | officer: CCO | M-Exempt | 11333 | 0.00 | 2.2 2026 | 40819 |
| Schafer Joshua | officer: CCO | M-Exempt | 35334 | 0.00 | 2.2 2026 | 72778 |
| Schafer Joshua | officer: CCO | A-Award | 75000 | 8.86 | 2.2 2026 | 75000 |
| Quartel Adrian W | officer: Chief Medical Officer | S-Sale | 4533 | 8.83 | 2.2 2026 | 9723 |
| Quartel Adrian W | officer: Chief Medical Officer | M-Exempt | 11333 | 0.00 | 2.2 2026 | 14256 |
| Quartel Adrian W | officer: Chief Medical Officer | M-Exempt | 11333 | 0.00 | 2.2 2026 | 22667 |
| Quartel Adrian W | officer: Chief Medical Officer | A-Award | 37500 | 0.00 | 2.2 2026 | 37500 |
| Quartel Adrian W | officer: Chief Medical Officer | A-Award | 75000 | 8.86 | 2.2 2026 | 75000 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | M-Exempt | 11333 | 0.00 | 2.2 2026 | 22667 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | A-Award | 37500 | 0.00 | 2.2 2026 | 37500 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | S-Sale | 4080 | 8.83 | 2.2 2026 | 49919 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | M-Exempt | 11333 | 0.00 | 2.2 2026 | 53999 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | A-Award | 75000 | 8.86 | 2.2 2026 | 75000 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | M-Exempt | 11666 | 0.00 | 2.2 2026 | 11668 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | M-Exempt | 6333 | 0.00 | 2.2 2026 | 12667 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | S-Sale | 1750 | 8.82 | 2.2 2026 | 20924 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | M-Exempt | 6333 | 0.00 | 2.2 2026 | 22674 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | M-Exempt | 11666 | 0.00 | 2.2 2026 | 32590 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | M-Exempt | 34000 | 0.00 | 7.1 2026 | 0 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | M-Exempt | 20000 | 0.00 | 7.1 2026 | 0 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | F-InKind | 48513 | 8.96 | 7.1 2026 | 143515 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | M-Exempt | 140667 | 0.00 | 7.1 2026 | 192028 |
| Secor Alicia | director: | 0 | 0.00 | 9.12 2025 | 0 | |
| Secor Alicia | director | A-Award | 45000 | 8.17 | 9.12 2025 | 45000 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 50000 | 0.00 | 10.10 2025 | 100000 |
| McFarlane Neil F. | director, officer: President and CEO | S-Sale | 19500 | 10.82 | 10.10 2025 | 222016 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 50000 | 0.00 | 10.10 2025 | 241516 |
| FAVORITO TAMARA A | director | P-Purchase | 3175 | 7.79 | 16.9 2025 | 3894 |
| Shih Alvin | director | P-Purchase | 20000 | 7.89 | 15.9 2025 | 20000 |
| Bode John B | director | P-Purchase | 5000 | 9.17 | 20.8 2025 | 45000 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | S-Sale | 24000 | 9.21 | 30.6 2025 | 42666 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | M-Exempt | 66666 | 0.00 | 24.6 2025 | 66666 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | M-Exempt | 66666 | 0.00 | 24.6 2025 | 133334 |
| Anderson Thomas | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| Bode John B | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| Watton Corey Michael | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| FAVORITO TAMARA A | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| Calder Douglas W | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| DIXON WENDY L | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| Shih Alvin | director | A-Award | 30000 | 8.62 | 30.5 2025 | 30000 |
| Watton Corey Michael | director | P-Purchase | 300 | 7.84 | 31.3 2025 | 1800 |
| Quartel Adrian W | officer: Chief Medical Officer | 300000 | 6.42 | 27.3 2025 | 0 | |
| Quartel Adrian W | officer: Chief Medical Officer | 0 | 0.00 | 27.3 2025 | 2923 | |
| Quartel Adrian W | officer: Chief Medical Officer | A-Award | 34000 | 0.00 | 27.3 2025 | 34000 |
| Quartel Adrian W | officer: Chief Medical Officer | A-Award | 68000 | 8.02 | 27.3 2025 | 68000 |
| Bode John B | director | P-Purchase | 10000 | 7.96 | 21.3 2025 | 40000 |
| McFarlane Neil F. | director, officer: President and CEO | S-Sale | 30544 | 8.05 | 14.2 2025 | 191516 |
| McFarlane Neil F. | director, officer: President and CEO | S-Sale | 61273 | 7.86 | 14.2 2025 | 222060 |
| Clifton R. LaDuane | officer: CFO & Treasurer | S-Sale | 11000 | 7.86 | 14.2 2025 | 51361 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | S-Sale | 10500 | 7.86 | 14.2 2025 | 29486 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | S-Sale | 3000 | 7.86 | 14.2 2025 | 16341 |
| McFarlane Neil F. | director, officer: President and CEO | A-Award | 112500 | 0.00 | 10.2 2025 | 112500 |
| McFarlane Neil F. | director, officer: President and CEO | A-Award | 225000 | 7.77 | 10.2 2025 | 225000 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 233333 | 0.00 | 3.2 2025 | 283333 |
| McFarlane Neil F. | director, officer: President and CEO | M-Exempt | 233333 | 0.00 | 3.2 2025 | 466667 |
| Clifton R. LaDuane | officer: CFO & Treasurer | A-Award | 34000 | 0.00 | 3.2 2025 | 34000 |
| Clifton R. LaDuane | officer: CFO & Treasurer | M-Exempt | 43333 | 0.00 | 3.2 2025 | 62361 |
| Clifton R. LaDuane | officer: CFO & Treasurer | A-Award | 68000 | 8.02 | 3.2 2025 | 68000 |
| Clifton R. LaDuane | officer: CFO & Treasurer | M-Exempt | 43333 | 0.00 | 3.2 2025 | 86667 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | A-Award | 34000 | 0.00 | 3.2 2025 | 34000 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | M-Exempt | 35333 | 0.00 | 3.2 2025 | 39986 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | A-Award | 68000 | 8.02 | 3.2 2025 | 68000 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | M-Exempt | 35333 | 0.00 | 3.2 2025 | 70667 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | A-Award | 34000 | 0.00 | 3.2 2025 | 34000 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | A-Award | 68000 | 8.02 | 3.2 2025 | 68000 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | A-Award | 19000 | 0.00 | 3.2 2025 | 19000 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | M-Exempt | 11666 | 0.00 | 3.2 2025 | 19341 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | M-Exempt | 11666 | 0.00 | 3.2 2025 | 23334 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | A-Award | 38000 | 8.02 | 3.2 2025 | 38000 |
| Watton Corey Michael | director | P-Purchase | 500 | 7.92 | 16.10 2024 | 1500 |
| Clifton R. LaDuane | officer: CFO & Treasurer | P-Purchase | 2000 | 6.77 | 17.7 2024 | 18469 |
| Anderson Thomas | director | P-Purchase | 10000 | 6.81 | 16.7 2024 | 20000 |
| Bode John B | director | P-Purchase | 10000 | 5.87 | 15.7 2024 | 30000 |
| Thompson Rahsaan | officer | 0 | 0.00 | 25.6 2024 | 0 | |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | A-Award | 200000 | 0.00 | 25.6 2024 | 200000 |
| DIXON WENDY L | director | A-Award | 39200 | 4.89 | 15.5 2024 | 39200 |
| Bode John B | director | A-Award | 39200 | 4.89 | 15.5 2024 | 39200 |
